L. Mekhael

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

E. Nordh, Yi-Chung Lee, R. Sommerville, 2020, Lancet Neurology.

Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis

J. Lechner-Scott, M. Trojano, F. Grand'Maison, 2016, European journal of neurology.

Phase 2 randomized placebo controlled double blind study to assess the efficacy and safety of tecfidera in patients with amyotrophic lateral sclerosis (TEALS Study)

S. Vucic, S. Mathers, M. Needham, 2020, Medicine.

Phase 2 randomized placebo controlled double blind study to assess the ef fi cacy and safety of tec fi dera in patients with amyotrophic lateral sclerosis ( TEALS Study ) Study protocol clinical trial ( SPIRIT Compliant )

S. Vucic, S. Mathers, M. Needham, 2020 .